![[logo] HealthTree Foundation](https://static.healthtree.org/icons/icon_spinner.svg){kind=icon}
![[logo] HealthTree Foundation](https://static.healthtree.org/logo_icon_only.svg){kind=icon}
Douglas Tremblay, MD
AML Specialist
Specialities: Myelofibrosis, Myelodysplastic Syndromes, Acute Myeloid Leukemia
Spoken languages: English
Clinical Expertise
- Acute Myeloid Leukemia
- Myelofibrosis
- Myelodysplastic Syndromes
- Acute Lymphoid Leukemia
About
Dr. Tremblay has led multi-institutional research efforts in myeloproliferative neoplasms and is actively involved in both investigator-initiated and industry sponsored early and late phase clinical trials in myeloid neoplasms.
Location
Mount Sinai Health System: 1470 Madison Ave #6th, New York, NY 10029, USA
All the HealthTree resources anywhere, anytime.
Download our App
Sign Up for Exclusive Blood Cancer Updates & Resources.
By subscribing to the Healthtree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.
Download our App
HealthTree Foundation is a qualified 501(c)(3) tax-exempt organization.
Copyright © 2025 HealthTree Foundation. All rights reserved.
Tax ID 45-5354811